DAVID MILLER: Open Payments
NPI 1417055369 · MAYWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 19 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,739 · 2025 $586
Food & beverage: $518Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $152 |
| Procept Biorobotics Corporation | 1 | $150 |
| Endo USA, Inc. | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $26 |
| Laborie Medical Technologies Corp. | 1 | $25 |
| Calyxo, Inc. | 1 | $23 |
| IMMUNITYBIO, INC. | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
Products named: AQUABEAM ROBOTIC SYSTEM, ERLEADA, RYBREVANT, AVEED, ORGOVYX, LYNPARZA, PYLARIFY, Optilume BPH Drug Coated Balloon Catheter.
Industry payments across NJ — which companies pay providers there.
